Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells

NCT01097057 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Non-Hodgkin Lymphoma

Interventions

DRUG: Carboplatin
DRUG: Etoposide
BIOLOGICAL: Filgrastim
DRUG: Ifosfamide
PROCEDURE: Leukapheresis
DRUG: Plerixafor
BIOLOGICAL: Rituximab

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]